WallStSmart

The Clorox Company (CLX)vsKimberly-Clark Corporation (KMB)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Kimberly-Clark Corporation generates 143% more annual revenue ($16.45B vs $6.76B). KMB leads profitability with a 12.3% profit margin vs 11.2%. CLX appears more attractively valued with a PEG of 2.17. KMB earns a higher WallStSmart Score of 52/100 (C-).

CLX

Buy

51

out of 100

Grade: C-

Growth: 2.0Profit: 7.5Value: 7.3Quality: 5.3
Piotroski: 5/9Altman Z: 2.08

KMB

Buy

52

out of 100

Grade: C-

Growth: 3.3Profit: 7.5Value: 6.0Quality: 4.0
Piotroski: 3/9Altman Z: 2.19
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CLXSignificantly Overvalued (-203.1%)

Margin of Safety

-203.1%

Fair Value

$41.55

Current Price

$104.76

$63.21 premium

UndervaluedFair: $41.55Overvalued
KMBUndervalued (+9.3%)

Margin of Safety

+9.3%

Fair Value

$118.58

Current Price

$99.36

$19.22 discount

UndervaluedFair: $118.58Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CLX2 strengths · Avg: 9.0/10
Return on EquityProfitability
98.7%10/10

Every $100 of equity generates 99 in profit

P/E RatioValuation
17.1x8/10

Attractively priced relative to earnings

KMB1 strengths · Avg: 10.0/10
Return on EquityProfitability
126.6%10/10

Every $100 of equity generates 127 in profit

Areas to Watch

CLX3 concerns · Avg: 2.7/10
PEG RatioValuation
2.174/10

Expensive relative to growth rate

Revenue GrowthGrowth
-0.8%2/10

Revenue declined 0.8%

EPS GrowthGrowth
-16.2%2/10

Earnings declined 16.2%

KMB4 concerns · Avg: 2.3/10
Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

PEG RatioValuation
6.892/10

Expensive relative to growth rate

Price/BookValuation
21.9x2/10

Trading at 21.9x book value

Revenue GrowthGrowth
-0.6%2/10

Revenue declined 0.6%

Comparative Analysis Report

WallStSmart Research

Bull Case : CLX

The strongest argument for CLX centers on Return on Equity, P/E Ratio.

Bull Case : KMB

The strongest argument for KMB centers on Return on Equity.

Bear Case : CLX

The primary concerns for CLX are PEG Ratio, Revenue Growth, EPS Growth.

Bear Case : KMB

The primary concerns for KMB are Piotroski F-Score, PEG Ratio, Price/Book. Debt-to-equity of 4.77 is elevated, increasing financial risk.

Key Dynamics to Monitor

CLX carries more volatility with a beta of 0.57 — expect wider price swings.

KMB is growing revenue faster at -0.6% — sustainability is the question.

KMB generates stronger free cash flow (575M), providing more financial flexibility.

Monitor HOUSEHOLD & PERSONAL PRODUCTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

KMB scores higher overall (52/100 vs 51/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

The Clorox Company

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

The Clorox Company, based in Oakland, California, is an American global manufacturer and marketer of consumer and professional products.

Kimberly-Clark Corporation

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Kimberly-Clark Corporation is an American multinational personal care corporation that produces mostly paper-based consumer products. The company manufactures sanitary paper products and surgical & medical instruments. Kimberly-Clark brand name products include Kleenex facial tissue, Kotex feminine hygiene products, Cottonelle, Scott and Andrex toilet paper, Wypall utility wipes, KimWipes scientific cleaning wipes and Huggies disposable diapers and baby wipes.

Visit Website →

Want to dig deeper into these stocks?